University of South Carolina Libraries
USC recognized for AIDS awareness Cultural Council gives bronze statue to university at Roger Center BY JESSICA CLANTON THE GAMECcfqK The Cultural Council of Richland and Lexington Counties unveiled an AIDS Awareness Sculpture on Monday to com mend the University of South Carolina on its progress in AIDS and HIV awareness. “We thought it was important to show our appreciation for all that USC does for HIV and AIDS education and prevention,” said Scott Lindenberg, public rela tions and marketing coordinator for the Cultural Council of Richland and Lexington Counties. USC President Andrew Sorensen, who once served as ex ecutive director of the AIDS Institute at the Johns Hopkins Medical Institutions, participat ed in the unveiling of the bronze sculpture of a 5-foot-2-inch wom an holding a quilt with the seal of the AIDS Benefit Foundation of South Carolina. “Sorensen’s leadership in the public health arena is good for the school and the AIDS and HIV cause, making it a perfect topic for us to promote educationally and prevent in the lives of stu dents,” said Larrell Wilkinson, project coordinator for the HIV testing at the Health and Wellness Center. Thursday from 10 a.m. to 5 p.m., the USC Health and Wellness Office will work in conjunction with the Richland Community Health Association to provide free HIV/AIDS testing to the USC com munity and public. “Getting tested is so important because students should know what their status is if they have practiced unsafe sex or have any other risk factors related to the HTV infection, so that they can ac cess and receive treatment as soon as possible,” said Marcous Gardner, program director for the Health and Wellness Office. The testing takes about five minutes and requires only a valid picture ID. The office expects 200 to 250 people to come for the test, which is taken with a cotton swab that absorbs enzymes from the mouth. “The Orasure test has been proven to be 99.97 percent effec tive in determining a positive or negative test and is safe and effi cient,” said Wilkinson. “We should receive the test results back in about two weeks.” The testing comes during the Sexual Responsibility Week spon sored by the USC Health and Wellness Center. “We want to challenge every one to come out and get tested be cause, here in South Carolina, ap proximately 15 percent of the re ported cases of new occurrences of HIV are in young people ages 20 to 29,” Wilkinson said. “Greenville, Charleston and Columbia are in the top 100 in the nation in metro area rankings for cases of HIV in terms of their pop ulation, and HIV is the number one cause of death in people, ages 24 to 44, in the nation.” “Some people might look at those numbers and say that they aren’t in that age range,” Wilkinson said. “But HIV can progress with in months or years, so what we are trying to do is ed ucate and promote safe behavior and try to prevent the spread of AIDS.” Comments on this story?E-mail gamecockudesk@hotmail.com Stadium CONTINUED FROM PAGE 1 gether and start working on what an agreement would look like,” McGee said. In June 2002, USC met with the new Bombers’ owners to begin dis cussions about the new stadium. No final plans have been made yet about how to finance the new stadium. McGee said the city has proposed an increase in the hos pitality tax, as well as getting money from both USC and the Bombers to finance the stadium. However, the proposal has yet to be brought up to the City Council for review. The idea of USC possibly having to shell out money for the stadium leaves some students uneasy. “For a school with a budget cri sis, we sure can throw around a lot of money,” said Zeke Walton, a fourth-year biology student. Sarge Frye Field, which is known more for its atmosphere and on-campus access, has been under a few renovations in the past. Some think that a move away from campus could hinder stu dents’ ability to go to the games. However, McGee said that was one of the stipulations that had to be agreed on before USC would enter into any proposals. The stadium had to be adjacent to USC’s campus “or we were not going to do it,” McGee said. Others think the upgrade to a new stadium could bring some im provements to the program. “It’ll be good for recruitment,” said Marc Medlin, a fourth-year hotel, restaurant and tourism management student. McGee said he does not foresee any problems with USC’s rela tionship with the Bombers but (| that there are a few details both parties have to hammer out. "We have to figure out things like practice facilities, coordina tion of practice times, space for our baseball offices, staffing, ad vertising — there’s a whole list of things we’ve been talking about,” McGee said. Comments on this story?E-mail gamecockudesk®hotmail.com <ou^ Ti cl<e.+ To ^3Kii'AQ Shenzhen Internship Program Spend a year teaching English conversation in the top-rated public school system of Shenzhen - China’s economic miracle, a vibrant, modern city of four million adjacent to Hong Kong. Begin with three weeks of training in Chinese language and in English teaching, [unxtan'*■'>* xsangfcn with classroom practice, at Beijing University in August. Then, teach 15 classes per ^ Wuhan week a* a Shenzhen junior-senior high school September 2003*- June 15, 2004. Optionally continue your study of Mandarin Chinese with college-credit courses and earn credits in an ESL practicum in Shenzhen. WHAT YOU RECEIVE YOUR NEXT STEP • Raund-trip ticket For more information, email or phone: • Free housing at Beijing University and Prof. William O'Donnell, University of Memphis train travel from Beijing to Shenzhen E-mail: chinapgm@cc.memphis.edu • Free faculty housing and some meals. Phone: 901 678-4584 office Shenzhen apartments have air-conditioning, 901 857-2930 cell enzhen telephone, and TV. Married couples can be Or visit our website: accommodated. http://www.chinaprogram.org • Stipend RMB 3,500 per month (approx $425) _ plus RMB 4,000 bonus in June *r?HA in an * Raid 3-week vacation at Chinese New Year in January/February i < London.$374 and NOT *’aris.*303 , Amsterdam...$303 jUSfc online Sydney.$1654 Madrid.$350 Rio de Janeiro..$508 » Fare is roundtrip from Columbia. Subject to change and availability. Tax not included. Restrictions and blackouts apply. I i'lic . -a,* • I 1I [Contraceptive Injection medroxyprogesterone acetate injectable suspension B>irth control pu-think a&out jus-t 4-xa^ear DEPO-PROVERA Contraceptive Injection (medroxyprogesterone acetate qectaWe suspension. USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramuscular injection (a shot) m the buttock or upper arm once every 3 months (13 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 ’weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg CMS from ripening. If an egg s not released from the wanes during your menstrual cycle, it carrot become fatted by sperm and result in pregnancy. DEPO-PROVERA also causes changes in foe tag of your uterus that make it less tely for pregnancy to occur How effectives DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PRuvERA Contraceptive Injection?). To make sure you are oot pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first ruction must be given ONLY during the first 5 days of a normal menstrual period: ONLY within foe first 5 days after chSdbkth if not breast-feeding and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a long-term injectable contraceptive when administered at 3-month (13-week) intervals. DEPO-PROVtRA Contraceptive Injection is over 99% effective, makrs it one of foe most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in pal on how reliably each woman uses the method. The effectiveness of DEPO -PROvERA depends only on foe patient returning every 3 months (13 weeks) for her next injection four health-care provider will help you compare DEPO-PROVERA with other contraceptive mefoods and give you the information yew need in order to decide which contraceptive method is the right choice for you. The (blowing table shows the percent of women who got pregiant wHe using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women who use each method exactly as it should be used) and foe typical rate of pregiancy (which includes women who became pregiant because foey forgot to use their birth control or because foey did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in foe First Year of Continuous Use Lowest Method_ ExpectedTypical DEPO-PROVERA0303 impana (Nkrplam)03^03* female dentation0204 Hale aerfaicn Ol OJS Oral contraceptive foil) - 5 Combmed 0.1 Progestogen pry OS - IUO 3 Rrogestasert 2.0 CcpperT 38QA08■ Condom (without spenxde)212 Diaphragm [with spermicide)618 Cerveai cjc218 Wthdrawal418 Pexxk anence1^920 Spemvcrie atone321 VagfeaJ Sponge used before childbirth 6 18 used ate cMdbinh928 I 35 1 8S Sotswr Trusses et at Obsat Cyneai. t99&7&5$8-567. •From Norplant* package nsm. Who should not use DEPO-PROVERA Contraceptive Injection? Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you have any of foe following conditions: t • if you think you might be pregiant ’ • if you have any vaginal bteetfingwifoout a known reason • if you hare had cancer of the breast • if you have had a stroke • f you have or have had blood ttois (phlebitis) in your legs • if you have problems with your fiver or liver disease • if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ocrectents). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You w# have a physical examination before your doctor prescribes DEPO-PROVERA It is important to te8 your health-care provider if you have any of the following • a family history of breast cancer • an abnormal mammogram (breast x-ray), fibrocystic breast dsease, breast nodules or lumps, or bleeding from your nipples • kidney disease • irregular or scanty menstrual periods • high blood pressure • migwe headaches • asthma • eplepsy (camdsoro or seism) • diabetes or a family history erf diabetes • a history of depression • if you are taking anyprescription or over-the-counter medications This product is intended to prevent pregnency. It does not protect ageinst transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, far women who slop using DEPO PROVERA in order to become pregnant it is expected that about half of those who become pregant will do so in about 10 months after thea last injection; about two thirds of those who become pregnant will do so in about 12 months; tibout 83% of those who become pregiant wit do so in about 15 months; and about 93% of those who become preaiant will do so in about 18 months after their last injection. The length of time you use D£K> PROVERA has no effect on how longit tateyou to become preaiant after you stop usng it What are the risks of using DEPO-^ROVt-RA Contraceptive Injection? I Irregikjr Menmot Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cyde. During the first year of using DEPO-PROVERA you might have one or more of the blowing chaws: irregular or unpredictable Weeding or spotting an increase or decrease in menstrual Weeding or w Weeding ases. and many women stop having periods completely. In clinical studies of DEPO PROVERA 55% of the women studied reported no menstrual bleedrig (amenorrhea) after I year of use, and 68% of the women studied'reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the regular monthly growth of the fining of your uterus does not occur and, therefore, the bleeding that conies with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period wi usually, in time, return to its normal cyde. 28or*Afeeraf Changes Use of DEPO-PROvERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your nsk of developing bane fractures. The rate of bone mineral loss 8 greatest in the early years of DEPO-PROVERA use, but after that it begins to resemble ffie normal rate of age-related bone mineral loss. IConcer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overal risk of developing cancer of the breast, ovary, uterus, cervix, or kver However, women under 35 years of age Whose first exposure to DEPO-PROVERA was within ihe previous 4 to 5 years may have a sfightly increased risk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your hearth-care provider TUnexpected Prwnencv Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regularly (every 3 months (13 weeks)) is very low While tliere have been reports of an mcreasedrisk of low birth weigjit and neonatal infant death or other health problems in infants concaved dose to the time of injection, such pregnancies are uncommon. If you think you may have become pregiant whte using DEPO-PROVERA for contraception, see your health-care provider as soon as possible. 5 Merge Reocms Some women using DEPO-PROVERA Contraceptive Injection have reported severe and potentially life-threatening alergic reactions known as anaphylaxis and anaphylactoid reactions. Symptoms vidude the sudden onset of hives or swelling and itching of the skin, breathing difficulties, aid a drop in blood pressure. ‘ bOtter fata Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a conn aceptive method fails, there is a possibility teat the fertilized egg wil begm g to develop outside of the uterus (ectopc pregnancy). While these events are rare, you should I tell your healthcare provider if you have any a the problem fisted in tee next section. What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Cal your healthcare provider immediately if any of these problems occur fblowmg an injection of DEPO-PROVERA • sharp chest pain, coupling up erf Wood, or sudden shortness of breath (indicating a possible dot in the king) • sudden severe headache or vomiting dizziness or fainting, problems with your eyesight or speech weakness, or numbness in an arm or leg (indicating a possible stroke) • severe pan or swelling in tee calf (indicating a possible dot in the leg) • unusual heavy vagina Weed#! »severe pain or tenderness in the lower abdominal area • persistent pan. pus, or Weeding at the injection site What are the possible side effects of DEPO-PROVERA Contraceptive Injection? I.We$tt <m You may experience a weight gain while you are using DEPO-PROVERA About two thirds of tee women who used DEPO-PROVERA in cfriical trials reported a weight gain of abewt 5 pounds during the first year of use. You may continue to gam weyjit after the first year- Women in one large study who used DEPO PROVERA for 2 years gained an average total of 8.1 pounds over car. Women who continued for 4 years gamed si '' yeartffomen those 8 years, or pounds per year. in a cWcal study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some I women reported the following effects that may or may not have been related to their use of ’ DEPO PROVERA Irregular menstrual bleeding amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea vaginal discharge or irritation, breast swWSng and tenderness, bloating, sweffing of the hands or fat, backache, depression, insomnia acne, pelvic pari, no hair growth or excessive hair loss, rash hot Sashes, and joint pain. Other problems were reported by very few of the women in tee clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, faulting, paralysis, osteoporosis, lads of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical cancer If these or any other problems occur duhng your use of DEPO PROVERA discuss teem with your healte care provider Should any precautions be followed during use of DEPO-PROVERA Contraceptive Injection? I Missed Periods Dunng Hie time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completely If you have been receiving your DEPO-PftOVtRA injections regularly every 3 months (13 weeks),then you are probably not pregnant However, if you think that you may be pregnant, see your health-care prartto ^laboratory Test bemctm If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO PROVERA for contraception. Certain Wood tests are affected by hormones such as DEPO-PROVERA 3,Dn» Interactions Cvtadren (ammogluteteimide) is an anticancer drug that may significantly decrease the effectiveness of DtPO-PROVtRA if the two drugs are given during the same time, ANunsra Mothers Although DEPO PROVERA can be passed to the nursing infant in tee breast mik, no harmful effects have been found ri these children. DEPO-PROVERA does not prevent tee breasts from producing mik so it can be used by nursing mothers. However, to minimize tee amount of DEPO-PROVERA that is passed to the infant ri tee first weeks after brte. you should wart until | ' ‘ ' . ~ DEPO-PROVERA for contraception. DVERA Contraceptive Injection? ISO mg every 3 months (13 weeks) given in a single intramuscular injection m the buttock or upper arm. To mate sure that you are not pregnant at tee time of the frst injection, it is essential that the injection be given ONLY during tfte first 5 days of a normal menstrual period If used following the delivery of a chdtLthe first injection of DEPO-PROVERA MUST be given within S days after childbirth if you are not breast-feeding or 6 weeks after childbirth if you are exclusively breast feeding. If you wait longer than 3 months (13 weeks) between injections, or longer than 6 weeks after detvery. your healthcare provider should determine that you are not pregnant before giving you your injection of DEPO-PROVERA Rxonly CB-7-S Pharmacia Pharmacia SUwohnComoary . ■ ItUfijOhn - Kalamazoo, Ml 49001. USA t 'i